Suppr超能文献

对头颈部鳞状细胞癌转移性颈部淋巴结病的快中子束远距治疗的评估。

An evaluation of fast neutron beam teletherapy of metastatic cervical adenopathy from squamous cell carcinomas of the head and neck region.

作者信息

Griffin T W, Laramore G E, Parker R G, Gerdes A J, Hebard D W, Blasko J C, Groudine M

出版信息

Cancer. 1978 Dec;42(6):2517-20. doi: 10.1002/1097-0142(197812)42:6<2517::aid-cncr2820420602>3.0.co;2-r.

Abstract

One hundred thirteen patients with metastatic cervical adenopathy (MCA) from advanced squamous cell carcinoma of the head and neck completed fast neutron beam irradiation between September 1976 and March 1977. With a maximum follow-up time of 49.9 months (mean 14.5 months), 54% of the total group remain disease-free at the sites of their cervical adenopathy. Control of adenopathy measuring 3 cm or less in maximum dimension was 75% with neutrons only and 87.5% with mixed beams. Nodes measuring 3-6 cm were controlled 38.1% of the time with neutrons only and 59% of the time with mixed beams. Clinical control of adenopathy measuring greater than 6 cm was obtained in 12.5% with neutrons only and 29.4% with mixed beams. For patients with controlled primary tumors, the overall control rate in the neck was 72%; 100% of nodes 3 cm or less were controlled, 82% of nodes measuring from 3-6 cm were controlled, and 42% of nodes greater than 6 cm were controlled. Patients with controlled primary tumors treated with mixed beams had 100% control of nodes measuring 3 cm or less, 96% control of nodes measuring 3-6 cm, and 50% control of nodes measuring greater than 6 cm. Overall, the control rate for mixed beams was significantly better than for treatment with neutrons only. Morbidity was less (both acute and late) in the mixed beam-irradiated group.

摘要

1976年9月至1977年3月期间,113例头颈部晚期鳞状细胞癌伴转移性颈部淋巴结肿大(MCA)的患者完成了快中子束照射。最大随访时间为49.9个月(平均14.5个月),整个队列中有54%的患者颈部淋巴结肿大部位无疾病。最大直径3 cm或更小的淋巴结,单纯中子照射的控制率为75%,混合束照射为87.5%。直径3 - 6 cm的淋巴结,单纯中子照射时38.1%的时间得到控制,混合束照射时59%的时间得到控制。直径大于6 cm的淋巴结,单纯中子照射时临床控制率为12.5%,混合束照射时为29.4%。对于原发肿瘤得到控制的患者,颈部总体控制率为72%;3 cm或更小的淋巴结100%得到控制,3 - 6 cm的淋巴结82%得到控制,大于6 cm的淋巴结42%得到控制。接受混合束治疗且原发肿瘤得到控制的患者,3 cm或更小的淋巴结控制率为100%,3 - 6 cm的淋巴结控制率为96%,大于6 cm的淋巴结控制率为50%。总体而言,混合束的控制率明显优于单纯中子治疗。混合束照射组的发病率(急性和晚期)更低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验